Apollo Ventures

Investing in Therapeutics for Aging Apollo Ventures is the first VC focused on building therapeutics to preventing age-related diseases and make us live longer and healthier. With offices in San Francisco and Hamburg, Apollo focuses on early stage companies in the US and Europe. Medications targeting age-related diseases and aging itself have drawn the attention of major pharma, technology, and investment companies the last two years, and the market for such drugs is at an inflection point. Join us and help us to find and nurture the next multi-billion therapeutics companies as well as catalyzing the next revolution of drug development.